ORBIMED ADVISORS LLC – Iovance Biotherapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$19.23M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -28.27% | -790.98K shares | -11.66M | $9.58 | 2.00M |
| Q2 2022 | share | Decrease | -57.81% | -3.83M shares | -79.54M | $11.04 | 2.79M |
| Q1 2022 | share | Increase | +4.66% | 295.30K shares | -10.54M | $16.65 | 6.63M |
| Q4 2021 | share | Decrease | -4.63% | -307.4K shares | -42.88M | $19.42 | 6.33M |
| Q3 2021 | share | 0.00% | 0 shares | -9.03M | $24.66 | 6.64M | |
| Q2 2021 | share | 0.00% | 0 shares | -37.47M | $26.02 | 6.64M | |
| Q1 2021 | share | 0.00% | 0 shares | -97.94M | $31.66 | 6.64M | |
| Q4 2020 | share | 0.00% | 0 shares | 89.57M | $46.4 | 6.64M | |
| Q3 2020 | share | 0.00% | 0 shares | 36.34M | $32.92 | 6.64M | |
| Q2 2020 | share | Increase | +19.77% | 1.09M shares | 16.31M | $27.45 | 6.64M |
| Q1 2020 | share | 0.00% | 0 shares | 12.51M | $29.94 | 5.54M | |
| Q4 2019 | share | 0.00% | 0 shares | 52.59M | $27.68 | 5.54M | |
| Q3 2019 | share | 0.00% | 0 shares | -35.06M | $18.2 | 5.54M | |
| Q2 2019 | share | 0.00% | 0 shares | 83.28M | $24.52 | 5.54M | |
| Q1 2019 | share | 0.00% | 0 shares | 3.66M | $9.51 | 5.54M | |
| Q4 2018 | share | 0.00% | 0 shares | -13.31M | $8.85 | 5.54M | |
| Q3 2018 | share | 0.00% | 0 shares | -8.6M | $11.25 | 5.54M | |
| Q2 2018 | share | 0.00% | 0 shares | -22.74M | $12.8 | 5.54M | |
| Q1 2018 | share | 0.00% | 0 shares | 49.38M | $16.9 | 5.54M | |
| Q4 2017 | share | Decrease | -13.65% | -877.3K shares | -5.41M | $8 | 5.54M |
| Q3 2017 | share | Increase | +89.94% | 3.04M shares | 24.59M | $7.75 | 6.42M |
| Q2 2017 | share | Increase | 0.00% | 3.38M shares | 25.20M | $7.35 | 3.38M |